subject area of
- 2017 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid‐Induced Osteoporosis Journal Articles
- A Translational Study of the Neoplastic Cells of Giant Cell Tumor of Bone Following Neoadjuvant Denosumab Journal Articles
- Atypical Femoral Fractures: A Teaching Perspective Journal Articles
- Bone Health and Bone-Targeted Therapies for Nonmetastatic Prostate Cancer Journal Articles
- Bone Health and Bone-targeted Therapies for Prostate Cancer: a Programme in Evidence-based Care — Cancer Care Ontario Clinical Practice Guideline Journal Articles
- Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ Journal Articles
- Clinical Efficacy and Safety of Denosumab in Postmenopausal Women with Low Bone Mineral Density and Osteoporosis: A Meta-Analysis Journal Articles
- Comparison of the clinical effectiveness and safety between the use of denosumab vs bisphosphonates in renal transplant patients Journal Articles
- Cost-effectiveness of Denosumab for the treatment of postmenopausal osteoporosis Journal Articles
- Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporosis in Canada Journal Articles
- Denosumab Treatment in Postmenopausal Women with Osteoporosis Does Not Interfere with Fracture-Healing Journal Articles
- Denosumab Versus Risedronate in Glucocorticoid‐Induced Osteoporosis: Final Results of a Twenty‐Four–Month Randomized, Double‐Blind, Double‐Dummy Trial Journal Articles
- Denosumab treatment for fibrous dysplasia Journal Articles
- Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study Journal Articles
- Denosumab, a new pharmacotherapy option for postmenopausal osteoporosis Journal Articles
- Denosumab: mechanism of action and clinical outcomes Journal Articles
- Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus Journal Articles
- Drug-Related Adverse Events of Osteoporosis Therapy Journal Articles
- Effect of low dose denosumab on bone mineral density in postmenopausal women with osteoporosis after a transition from 60 mg dose: a prospective observational study Journal Articles
- FRAME Study: The Foundation Effect of Building Bone With 1 Year of Romosozumab Leads to Continued Lower Fracture Risk After Transition to Denosumab Journal Articles
- Fracture risk and treatment in chronic kidney disease Journal Articles
- Further reductions in nonvertebral fracture rate with long-term denosumab treatment in the FREEDOM open-label extension and influence of hip bone mineral density after 3 years Journal Articles
- Glucocorticoid induced osteoporosis Journal Articles
- Hypocalcemia Risk of Denosumab Across the Spectrum of Kidney Disease: A Population-Based Cohort Study Journal Articles
- Impact of denosumab on the peripheral skeleton of postmenopausal women with osteoporosis Journal Articles
- Influence of subject discontinuation on long-term nonvertebral fracture rate in the denosumab FREEDOM Extension study Journal Articles
- Occurrence of Serious Infection in Patients with Rheumatoid Arthritis Treated with Biologics and Denosumab Observed in a Clinical Setting Conferences
- One Year of Romosozumab Followed by Two Years of Denosumab Maintains Fracture Risk Reductions: Results of the FRAME Extension Study Journal Articles
- Persistence at 12 months with denosumab in postmenopausal women with osteoporosis: interim results from a prospective observational study Journal Articles
- Persistence at 24 months with denosumab among postmenopausal women with osteoporosis: results of a prospective cohort study Journal Articles
- Persistence with denosumab therapy among osteoporotic women in the Canadian patient-support program Journal Articles
- Pharmacologic Treatment of Primary Osteoporosis or Low Bone Mass to Prevent Fractures in Adults: A Living Clinical Guideline From the American College of Physicians Journal Articles
- Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology–Cancer Care Ontario Focused Guideline Update Journal Articles
- Romosozumab Treatment in Postmenopausal Women with Osteoporosis Journal Articles
- Systematic review of the effect of denosumab on children with osteogenesis imperfecta showed inconsistent findings Journal Articles
- The Effect of Discontinuing Denosumab in Patients With Rheumatoid Arthritis Treated With Glucocorticoids. Conferences
- The Efficacy and Safety of Medical and Surgical Therapy in Patients With Primary Hyperparathyroidism: A Systematic Review and Meta-Analysis of Randomized Controlled Trials Journal Articles
- The Role of Denosumab for Surgical Outcomes in Patients with Giant Cell Tumour of Bone: A Systematic Review Journal Articles
- Treatment of Low Bone Density or Osteoporosis to Prevent Fractures in Men and Women: A Clinical Practice Guideline Update From the American College of Physicians Journal Articles
- Treatment with Denosumab Reduces the Incidence of New Vertebral and Hip Fractures in Postmenopausal Women at High Risk Journal Articles
- Treatment with denosumab reduces secondary fracture risk in women with postmenopausal osteoporosis Journal Articles
- Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Skeletal Metastases from Lung Cancer? A Systematic Review and Network Meta-analysis Journal Articles